These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6296187)

  • 1. Studies on the regulation of phosphodiesterase in human adipose tissue in vitro.
    Engfeldt P; Arner P; Ostman J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):501-6. PubMed ID: 6296187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of insulin and lipolytic hormones on cyclic AMP phosphodieterase activity in normal and diabetic rat adipose tissue.
    Solomon SS
    Endocrinology; 1975 Jun; 96(6):1366-73. PubMed ID: 165058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man.
    Moberg E; Enoksson S; Hagström-Toft E
    Horm Metab Res; 1998 Nov; 30(11):684-8. PubMed ID: 9918386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation, by insulin, of lipoprotein lipase and phosphodiesterase activities in rat adipose tissue.
    Desai K; Hollenberg CH
    Isr J Med Sci; 1975 Jun; 11(6):540-50. PubMed ID: 169209
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase activities from isolated fat cells: correlation of subcellular distribution with effects of nucleotides and insulin.
    Sakai T; Thompson WJ; Lavis VR; Williams RH
    Arch Biochem Biophys; 1974 Jun; 162(2):331-9. PubMed ID: 4366367
    [No Abstract]   [Full Text] [Related]  

  • 6. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man.
    Enoksson S; Degerman E; Hagström-Toft E; Large V; Arner P
    Diabetologia; 1998 May; 41(5):560-8. PubMed ID: 9628274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
    Smith CJ; Manganiello VC
    Mol Pharmacol; 1989 Mar; 35(3):381-6. PubMed ID: 2538713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal control of adipose-tissue lipolysis.
    Hales CN; Luzio JP; Siddle K
    Biochem Soc Symp; 1978; (43):97-135. PubMed ID: 219867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effect of insulin on cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in fat cells.
    Manganiello V; Vaughan M
    J Biol Chem; 1973 Oct; 248(20):7164-70. PubMed ID: 4355201
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
    Simmons MA; Hartzell HC
    Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of insulin and lipolytic agents on rat adipocyte low Km cyclic adenosine 3':5'-monophosphate phosphodiesterase.
    Zinman B; Hollenberg CH
    J Biol Chem; 1974 Apr; 249(7):2182-7. PubMed ID: 4362065
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of adipocyte isolation by collagenase on phosphodiesterase activity and lipolysis in man.
    Engfeldt P; Arner P; Ostman J
    J Lipid Res; 1980 May; 21(4):443-8. PubMed ID: 6247409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of 3',5'-cyclic amp phosphodiesterase in insulin action on rat liver and adipose tissue.
    Hepp D; Menahan A; Wieland O
    Horm Metab Res; 1969 Mar; 1(2):93-4. PubMed ID: 4334869
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of human placental cytosolic adenosine 3',5'-monophosphate phosphodiesterase by inhibitors and insulin treatment.
    Xiong LM; LeBon TR; Fujita-Yamaguchi Y
    Endocrinology; 1990 Apr; 126(4):2102-9. PubMed ID: 2156681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for separate sites of action for the antilipolytic effects of insulin and prostaglandin E1.
    Loten EG; Sneyd JG
    Endocrinology; 1973 Dec; 93(6):1315-22. PubMed ID: 4356613
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of somatomedin C on insulin-sensitive phosphodiesterase in rat fat cells.
    Kuribayashi N; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1988 Jul; 37(7):635-9. PubMed ID: 2838732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on pyrazinoylguanidine. 4. Upregulation of phosphodiesterase activity in rat adipose tissue and downregulation of gluconeogenesis and adenosine 3',5'-monophosphate concentrations in perfused rat liver.
    A-Rahim YI; Rannels SL; Kimball SR; Beyer KH; Vesell ES
    Pharmacology; 1996 Oct; 53(4):211-8. PubMed ID: 8958559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase activity in human subcutaneous adipose tissue in insulin- and noninsulin-dependent diabetes mellitus.
    Engfeldt P; Arner P; Bolinder J; Ostman J
    J Clin Endocrinol Metab; 1982 Nov; 55(5):983-8. PubMed ID: 6288760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation.
    Gantner F; Götz C; Gekeler V; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1998 Mar; 123(6):1031-8. PubMed ID: 9559883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
    Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
    J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.